June 25, 1982: Headlines: Malaria: COS - Kenya: COS - Tanzania: COS - Uganda: COS - Madagascar: COS - Comoros: Infectious Diseases: Safety and Security of Volunteers: CDC: Revised Recommendations for Malaria Chemoprophylaxis for Travelers to East Africa

Peace Corps Online: Peace Corps News: Peace Corps Library: Malaria: Peace Corps: Malaria : The Peace Corps and Malaria: June 25, 1982: Headlines: Malaria: COS - Kenya: COS - Tanzania: COS - Uganda: COS - Madagascar: COS - Comoros: Infectious Diseases: Safety and Security of Volunteers: CDC: Revised Recommendations for Malaria Chemoprophylaxis for Travelers to East Africa

By Admin1 (admin) (pool-141-157-13-244.balt.east.verizon.net - on Saturday, January 22, 2005 - 12:11 am: Edit Post

Revised Recommendations for Malaria Chemoprophylaxis for Travelers to East Africa

Revised Recommendations for Malaria Chemoprophylaxis for Travelers to East Africa

Revised Recommendations for Malaria Chemoprophylaxis for Travelers to East Africa

The following statement updates information published in the "East Africa" section of the MMWR supplement, "Prevention of Malaria in Travelers, 1982" (MMWR Vol. 31/No.1S, p. 24S) dated April 16, 1982.

Infections with chloroquine-resistant Plasmodium falciparum malaria acquired by travelers to East Africa were first reported in 1978 (1). Since then, there have been a number of similar case reports in the world literature, all describing chloroquine-prophylaxis and/or -treatment failures in non-immune travelers to East Africa (2-4).

In the past 18 months, an additional 19 such cases of chloroquine-prophylaxis failure among U.S. travelers have been reported to and documented by CDC. When available, chloroquine levels in blood tested at the time of diagnosis have corroborated the history of chloroquine prophylaxis. In several instances, malaria parasites from these patients have been adapted to in vitro culture, and in vitro drug-sensitivity testing has confirmed the parasites' in vivo resistance to chloroquine. To date, the countries in which chloroquine-resistant infections in non-immune travelers have been acquired include: Kenya, Tanzania, Uganda, Madagascar, and Comoros (5). There have been no documented cases from West Africa.

These data offer compelling evidence that chloroquine-resistant P. falciparum transmission is widely dispersed in East Africa, and that there is substantial risk of infection for American travelers, despite chloroquine prophylaxis. Foreign Service officers, Peace Corps volunteers, missionaries, and workers who live for extended periods in areas with high transmission may be at particular risk. Consultation with medical personnel of the U. S. Department of State and of the Peace Corps confirms that cases of chloroquine prophylaxis failure have occurred in these groups within the past year.

Fansidar* is the drug most commonly used to suppress chloroquine-resistant P. falciparum malaria. Each tablet contains a fixed combination of pyrimethamine, 25 mg, and sulfadoxine, 500 mg. Fansidar was licensed for sale in the United States in January 1982.

Chloroquine and the 2 components of Fansidar interrupt different metabolic pathways of the malaria parasite. Therefore, while the risk of acquiring malaria can never be completely eliminated, available information indicates that the combination of chloroquine with Fansidar will be substantially more effective prophylactically than Fansidar alone. When Fansidar prophylaxis is indicated, chloroquine should always be taken concurrently because: 1) Fansidar alone may not always be efficacious (even against sensitive strains of P. falciparum) due to "host failure" (6), 2) the addition of chloroquine may retard the emergence of Fansidar-resistant malaria, and 3) the effectiveness of Fansidar as a prophylaxis for the other species of human malaria in East Africa has not been adequately documented.

On the basis of accumulating evidence and the advice of a recently convened group of experts, CDC's recommendations now are: Fansidar, 1 tablet once weekly PLUS chloroquine 300 mg (base) once weekly. Weekly doses of Fansidar and chloroquine may be taken on the same day, at the same time. Contraindications to Fansidar


Pregnant women. Fansidar is not recommended for pregnant women, due to results of animal studies suggesting that pyrimethamine may have teratogenic potential. Pregnant women who cannot avoid travel to areas of the world with chloroquine-resistant malaria should use chloroquine alone as prophylaxis. Health-care providers should advise these patients that they are at increased risk of acquiring malaria, and should be especially alert for the development of a febrile illness.

Allergy to sulfonamides. The use of Fansidar is contraindicated for persons allergic to sulfonamides; a pyrimethamine-dapsone combination (marketed overseas as Maloprim) may be useful for individuals who do not have cross-hypersensitivity to sulfones. Of note, hematologic toxicity attributed to dapsone has been reported when it has been taken for malaria prophylaxis (7).

Children under 2 months old. Fansidar should not be given to children 2 months of age, as sulfa drugs may induce neonatal jaundice. Chloroquine may be given to newborns, but parents should be aware of the potential for prophylaxis failure in areas where transmission of chloroquine-resistant malaria is known to occur. Long-Term Use of Fansidar.

There have been few studies of the long-term side effects of Fansidar prophylaxis (8,9), and no studies of the side effects of concurrent use of both chloroquine and Fansidar. Long-term administration of pyrimethamine may induce megaloblastic anemia, leukopenia, or other hematologic toxicity. While these side effects are usually reversible, routine hemograms should be obtained from persons on Fansidar prophylaxis for longer than 6 months. Reported by Malaria Br, Div of Parasitic Diseases, Center for Infectious Diseases, CDC.



CDC. Chloroquine-resistant malaria acquired in Kenya and Tanzania--Denmark, Georgia, New York. MMWR 1978;27:463-4.

Faehlmann M, Rombo L, Hedman P. Serum concentrations of chloroquine in a patient with a late recrudescence of Kenyan Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1981;75:362-4.

Gardner AL, Weinstein RA, Lincoln LJ. Failure of chloroquine prophylaxis in Plasmodium falciparum from East Africa. JAMA 1981;246:979-80.

Bengtsson E, Bjorkman A, Brohult J, et al. Malaria prophylaxis when visiting areas of East Africa with chloroquine resistance. Lancet 1981;2:249.

CDC. Chloroquine-resistant Plasmodium falciparum malaria acquired in East Africa--Pennsylvania. MMWR 1981;30:525-6.

CDC. Problems encountered with using Fansidar as prophylaxis for malaria. MMWR 1982;31:232-4.

Ognibene, AJ. Agranulocytosis due to dapsone. Ann Intern Med 1970;72:521-4.

Ebisawa I, Muto T, Mitsui G, Kameko S. Malaria at Nam Ngum Dam construction site in Laos. Jap J Exp Med 1971;41:209-19.

O'Holohan DR, Hugoe-Matthews J. Malaria suppression and prophylaxis on a Malaysian rubber estate: sulformethoxine-pyrimethamine single monthly dose vs chloroquine single weekly dose. Southeast Asian J Trop Med Public Health 1971;2:164-8. *Use of trade names is for identification only and does not imply endorsement by the Public Health Service or the U.S. Department of Health and Human Services.

Disclaimer All MMWR HTML documents published before January 1993 electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Page converted: 08/05/98

When this story was posted in December 2004, this was on the front page of PCOL:

Our debt to Bill Moyers Our debt to Bill Moyers
Former Peace Corps Deputy Director Bill Moyers leaves PBS next week to begin writing his memoir of Lyndon Baines Johnson. Read what Moyers says about journalism under fire, the value of a free press, and the yearning for democracy. "We have got to nurture the spirit of independent journalism in this country," he warns, "or we'll not save capitalism from its own excesses, and we'll not save democracy from its own inertia."

December 10, 2004: This Week's Top Stories December 10, 2004: This Week's Top Stories
Dodd says Rumsfeld's answer was unacceptable 9 Dec
RPCV Blake Willeford runs classic movie theatre 9 Dec
RPCV says education is key to curbing AIDS 9 Dec
RPCV Dannielle Tegeder opens exhibition 9 Dec
Shalala 1st Woman In Touchdown Club 9 Dec
"Today we have a new country" says Toledo 9 Dec
DDN wins Investigative Reporting Award 8 Dec
Celeste on Panel to study Colorado finances 8 Dec
RPCV leads Rotary Club medical team to Togo 6 Dec
Vasquez to speak at Hawaii, Wisconsin commencements 6 Dec
Tom Murphy warns Pittsburgh on budget abyss 2 Dec
Venezuela RPCV Martha Egan runs Pachamama imports 30 Nov
more top stories...

RPCV safe after Terrorist Attack RPCV safe after Terrorist Attack
RPCV Gina Abercrombie-Winstanley, the U.S. consul general in Jeddah, Saudi Arabia survived Monday's attack on the consulate without injury. Five consular employees and four others were killed. Abercrombie-Winstanley, the first woman to hold the position, has been an outspoken advocate of rights for Arab women and has met with Saudi reformers despite efforts by Saudi leaders to block the discussions.
Is Gaddi Leaving? Is Gaddi Leaving?
Rumors are swirling that Peace Corps Director Vasquez may be leaving the administration. We think Director Vasquez has been doing a good job and if he decides to stay to the end of the administration, he could possibly have the same sort of impact as a Loret Ruppe Miller. If Vasquez has decided to leave, then Bob Taft, Peter McPherson, Chris Shays, or Jody Olsen would be good candidates to run the agency. Latest: For the record, Peace Corps has no comment on the rumors.
The Birth of the Peace Corps The Birth of the Peace Corps
UMBC's Shriver Center and the Maryland Returned Volunteers hosted Scott Stossel, biographer of Sargent Shriver, who spoke on the Birth of the Peace Corps. This is the second annual Peace Corps History series - last year's speaker was Peace Corps Director Jack Vaughn.
Vote "Yes" on NPCA's bylaw changes Vote "Yes" on NPCA's bylaw changes
Take our new poll. NPCA members begin voting this week on bylaw changes to streamline NPCA's Board of Directors. NPCA Chair Ken Hill, the President's Forum and other RPCVs endorse the changes. Mail in your ballot or vote online (after Dec 1), then see on how RPCVs are voting.
Charges possible in 1976 PCV slaying Charges possible in 1976 PCV slaying
Congressman Norm Dicks has asked the U.S. attorney in Seattle to consider pursuing charges against Dennis Priven, the man accused of killing Peace Corps Volunteer Deborah Gardner on the South Pacific island of Tonga 28 years ago. Background on this story here and here.
Your vote makes a difference Your vote makes a difference
Make a difference on November 2 - Vote. Then take our RPCV exit poll. See how RPCV's are voting and take a look at the RPCV voter demographic. Finally leave a message on why you voted for John Kerry or for George Bush. Previous poll results here.

Read the stories and leave your comments.

Some postings on Peace Corps Online are provided to the individual members of this group without permission of the copyright owner for the non-profit purposes of criticism, comment, education, scholarship, and research under the "Fair Use" provisions of U.S. Government copyright laws and they may not be distributed further without permission of the copyright owner. Peace Corps Online does not vouch for the accuracy of the content of the postings, which is the sole responsibility of the copyright holder.

Story Source: CDC

This story has been posted in the following forums: : Headlines; Malaria; COS - Kenya; COS - Tanzania; COS - Uganda; COS - Madagascar; COS - Comoros; Infectious Diseases; Safety and Security of Volunteers



Add a Message

This is a public posting area. Enter your username and password if you have an account. Otherwise, enter your full name as your username and leave the password blank. Your e-mail address is optional.